Page 178 - 2019_12-Haematologica-web

S.N. Chaurasia et al.
activity mediate hypoxia-induced pro-
thrombotic phenotype. Blood. 2014;123(8):
1250-1260.
17. Yan S-F, Zou YS, Gao Y, et al. Tissue factor
transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci U S A. 1998;95(14):8298-8303.
18. Pinsky DJ, Liao H, Lawson CA, et al. Coordinated induction of plasminogen acti- vator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fib- rin deposition. J Clin Invest. 1998;102(5): 919-928.
19. Weyrich AS, Dixon DA, Pabla R, et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci U S A. 1998;95(10):5556- 5561.
20. Lindemann S, Tolley ND, Dixon DA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta syn- thesis. J Cell Biol. 2001;154(3):485-490.
21. Brogren H, Karlsson L, Andersson M, Wang L, Erlinge D, Jern S. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood. 2004;104(13):3943-3948.
22. Panes O, Matus V, Saez CG, Quiroga T, Pereira J, Mezzano D. Human platelets syn- thesize and express functional tissue factor. Blood. 2007;109(12):5242-5250.
23. Kumari S, Dash D. Melatonin elevates intra- cellular free calcium in human platelets by inositol 1,4,5-trisphosphate independent mechanism. FEBS Lett. 2011;585(14):2345- 2351.
24. Kulkarni PP, Tiwari A, Singh N, Gautam D, Sonkar VK, Agarwal V, Dash D. Aerobic gly-
colysis fuels platelet activation: small-mole- cule modulators of platelet metabolism as anti-thrombotic agents. Haematologica 2019;104(4):806-818.
25. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260(6):3440-3450.
26. Selfridge AC, Cavadas MA, Scholz CC, et al. Hypercapnia suppresses the HIF-dependent adaptive response to hypoxia. J Biol Chem. 2016;291(22):11800-11808.
Mechanism of platelet adhesion to von Willebrand factor and microparticle forma- tion under high shear stress. Blood. 2006;107(9):3537-3545.
33. Sinauridze EI, Kireev DA, Popenko NY, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost. 2007;97(3):425-434.
34. Mallick RL, Kumari S, Singh N, Sonkar VK, Dash D. Prion protein fragment (106-126) induces prothrombotic state by raising platelet intracellular calcium and microparti- cle release. Cell Calcium. 2015;57(4):300-
27. Thompson AA, Elks PM, Marriott HM, et al. Hypoxia-inducible factor 2alpha regulates
key neutrophil functions in humans, mice, 311.
and zebrafish. Blood. 2014;123(3):366-376. 28. Kramer RM, Roberts EF, Strifler BA, Johnstone EM. Thrombin induces activation of p38 MAP kinase in human platelets. J Biol
Chem. 1995;270(46):27395-27398.
29. Nayak MK, Kumar K, Dash D. Regulation of proteasome activity in activated human
platelets. Cell Calcium. 2011;49(4):226-232. 30. Carroll VA, Ashcroft M. Role of hypoxia- inducible factor (HIF)-1alpha versus HIF- 2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau func- tion: implications for targeting the HIF path-
way. Cancer Res. 2006;66(12):6264-6270. 31. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999;94(11):
3791-3799.
32. Reininger AJ, Heijnen HFG, Schumann H,
Specht HM, Schramm W, Ruggeri ZM.
35. Huber J, Vales A, Mitulovic G, et al. Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce mono- cyte-endothelial interactions. Arterioscler Thromb Vasc Biol. 2002;22(1):101-107.
36. Wouters EF, Groenewegen KH, Dentener MA, Vernooy JH. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc. 2007;4(8):626-634.
37. Maclay JD, McAllister DA, Johnston S, et al. Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax. 2011;66(9):769-774.
38. McRedmond JP, Park SD, Reilly DF, et al. Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics. 2004;3(2):133-144.
39. Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22: 809-814.
2492
haematologica | 2019; 104(12)